Evidence map›Paper›PMID 34183822›Full record

ReviewNature reviews. Microbiology2021

Antibiofilm activity of host defence peptides: complexity provides opportunities.

Robert E W Hancock, Morgan A Alford, Evan F Haney

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 1 pooled it
25.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 1 synthesis or guideline pooled it, 240 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. The potential role of HNature communications · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Synergistic Action of Antimicrobial Peptides and Antibiotics.International journal of molecular sciences · 2026
    Review
  20. Computer-Aided Design ofACS medicinal chemistry letters · 2026
    Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Robert E W HancockDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada. bob@hancocklab.com.ORCID http://orcid.org/0000-0001-5989-8503
Morgan A Alford *Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0002-4446-817X
Evan F Haney *Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0003-3645-770X
University of British Columbia · CA

Funding

CIHR FDN-154287
6 · The paper itself

Abstract

Host defence peptides (HDPs) are integral components of innate immunity across all living organisms. These peptides can exert direct antibacterial effects, targeting planktonic cells (referred to as antimicrobial peptides), and exhibit antibiofilm (referred to as antibiofilm peptides), antiviral, antifungal and host-directed immunomodulatory activities. In this Review, we discuss how the complex functional attributes of HDPs provide many opportunities for the development of antimicrobial therapeutics, focusing particularly on their emerging antibiofilm properties. The mechanisms of action of antibiofilm peptides are compared and contrasted with those of antimicrobial peptides. Furthermore, obstacles for the practical translation of candidate peptides into therapeutics and the potential solutions are discussed. Critically, HDPs have the value-added assets of complex functional attributes, particularly antibiofilm and anti-inflammatory activities and their synergy with conventional antibiotics.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesAntiviral AgentsBiofilmsImmunity, InnateImmunomodulating AgentsAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsAnti-Inflammatory AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesAntiviral AgentsImmunomodulating Agents

Identifiers

PMID34183822
OpenAlexW3175863350

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.